SE8301565L - OIL SOLUBLE COMPOSITION CONTAINING FAT SOLUBLE VITAMIN - Google Patents

OIL SOLUBLE COMPOSITION CONTAINING FAT SOLUBLE VITAMIN

Info

Publication number
SE8301565L
SE8301565L SE8301565A SE8301565A SE8301565L SE 8301565 L SE8301565 L SE 8301565L SE 8301565 A SE8301565 A SE 8301565A SE 8301565 A SE8301565 A SE 8301565A SE 8301565 L SE8301565 L SE 8301565L
Authority
SE
Sweden
Prior art keywords
soluble
vitamin
oil
composition containing
containing fat
Prior art date
Application number
SE8301565A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8301565D0 (en
SE461892B (en
Inventor
Y Yamamoto
T Okada
S Morioka
T Kaneko
Original Assignee
Sato Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sato Pharma filed Critical Sato Pharma
Publication of SE8301565D0 publication Critical patent/SE8301565D0/en
Publication of SE8301565L publication Critical patent/SE8301565L/en
Publication of SE461892B publication Critical patent/SE461892B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An oil-soluble composition contains fat-soluble vitamin B2 butyrate with an oily solubilizing agent comprising a glycerin ester of a fatty acid, a sorbitan ester of a fatty acid, a polyoxyethylenesorbitan ester of a fatty acid, or a mixture of these esters. The vitamin is present in an amount of up to 25% by weight of the composition. The oil-soluble composition can be formulated in soft, hard or micro capsules.
SE8301565A 1982-05-31 1983-03-22 OIL-SOLUBLE COMPOSITION OF VITAMIN B BUTYRATE SE461892B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57091466A JPS58208215A (en) 1982-05-31 1982-05-31 Oil-soluble composition containing fat-soluble vitamin

Publications (3)

Publication Number Publication Date
SE8301565D0 SE8301565D0 (en) 1983-03-22
SE8301565L true SE8301565L (en) 1983-12-01
SE461892B SE461892B (en) 1990-04-09

Family

ID=14027151

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8301565A SE461892B (en) 1982-05-31 1983-03-22 OIL-SOLUBLE COMPOSITION OF VITAMIN B BUTYRATE

Country Status (6)

Country Link
JP (1) JPS58208215A (en)
CH (1) CH656531A5 (en)
DE (1) DE3311008C2 (en)
FR (1) FR2527440B1 (en)
GB (1) GB2120935B (en)
SE (1) SE461892B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS63130535A (en) * 1986-11-19 1988-06-02 Nisshin Kagaku Kk Antihistamine agent for oral administration
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
SG115386A1 (en) 1997-01-30 2005-10-28 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8014M (en) * 1968-01-09 1970-07-27
US3962436A (en) * 1969-06-03 1976-06-08 Sumitomo Chemical Company, Limited Pharmaceutical compositions having controlled rate of gastro-intestinal absorption
NL7012460A (en) * 1970-08-22 1972-02-24
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations

Also Published As

Publication number Publication date
FR2527440B1 (en) 1987-05-15
CH656531A5 (en) 1986-07-15
GB8307543D0 (en) 1983-04-27
GB2120935A (en) 1983-12-14
FR2527440A1 (en) 1983-12-02
DE3311008A1 (en) 1983-12-01
GB2120935B (en) 1985-10-23
JPH044299B2 (en) 1992-01-27
SE8301565D0 (en) 1983-03-22
DE3311008C2 (en) 1986-04-10
JPS58208215A (en) 1983-12-03
SE461892B (en) 1990-04-09

Similar Documents

Publication Publication Date Title
KR900013063A (en) Oxidation Inhibitor Method
KR880008797A (en) Skin care composition containing silymarin
ES2050824T3 (en) GREASE COMPOSITION FOR CHILDREN'S FORMULAS.
KR910000122A (en) Powder preparation and preparation method thereof
KR840005339A (en) Method for preparing an aqueous solution containing a fat soluble substance
ES496393A0 (en) A PROCEDURE FOR THE PRODUCTION OF A COSM-ETHICAL COMPOSITION
DE69403025D1 (en) Cosmetic or dermatological preparation in the form of a stable oil-in-water emulsion which contains at least one vegetable oil which consists of at least 40% linoleic acid triglyceride
NO882134L (en) PREPARATION OF FLUNARIZIN CONTAINING PREPARATIONS.
SE8301565D0 (en) OIL SOLUBLE COMPOSITION CONTAINING FAT SOLUBLE VITAMIN
JPS5747446A (en) Nutrious food composition
DK0456764T3 (en) Omega-3 fatty acid-containing fat emulsion for endotracheal administration, preparation and use thereof
JPS5640605A (en) Cosmetic
DE68901222D1 (en) FAT-SOLUBLE VITAMIN K CONTAINING WATER SOLUTION.
KR870005644A (en) Manufacturing method of powder composite
JPS5446821A (en) Preparation of drug for soft capsule
JPS5549313A (en) Vitamin pharmaceutical and its preparation
JPS5449337A (en) W/o-type cosmetic stick
JPS5460303A (en) Antioxidant for fat and oil and method of preventing oxidation
KR910015303A (en) Stabilized fat-soluble vitamin composition
JPS56161315A (en) Oil-soluble skin anatriptic of ferulic ester
JPS55133480A (en) Antioxidant
JPS55105623A (en) Preparation of filler for hard capsules
JPS5432187A (en) Defoaming agent
ES8601693A1 (en) Antimycotic Agent With a High Release of Active Compounds, in the Form of a Cream
JPS53127839A (en) Milky skin lotion composition

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8301565-1

Format of ref document f/p: F

NUG Patent has lapsed